Docetaxel chemotherapy remains the standard of care in castration-resistant prostate cancer (Q46468071)
Jump to navigation
Jump to search
scientific article published on 22 July 2008
Language | Label | Description | Also known as |
---|---|---|---|
English | Docetaxel chemotherapy remains the standard of care in castration-resistant prostate cancer |
scientific article published on 22 July 2008 |
Statements
1 reference
Docetaxel chemotherapy remains the standard of care in castration-resistant prostate cancer (English)
1 reference
1 reference
Brian Schurko
1 reference
22 July 2008
1 reference
5
1 reference
9
1 reference
506-507
1 reference
Identifiers
1 reference